Literature DB >> 15723204

Is there a role of taurine bromamine in inflammation? Interactive effects with nitrite and hydrogen peroxide.

J Marcinkiewicz1, M Mak, M Bobek, R Biedroń, A Białecka, M Koprowski, E Kontny, W Maśliński.   

Abstract

OBJECTIVE AND <br> DESIGN: The myeloperoxidase system of neutrophils generates chlorinating and brominating oxidants in vivo. The major haloamines of the system are taurine chloramine (TauCl) and taurine bromamine (TauBr). It has been demonstrated in vitro that TauCl exerts both antiinflammatory and anti-bacterial properties. Much less is known about TauBr. The present study was conducted to compare bactericidal and immunoregulatory capacity of TauBr with that of the major chlorinating oxidants: HOCl and TauCl. Moreover, the effect of nitrites and H(2)O(2) on TauBr activity was investigated. MATERIALS: TauBr was prepared by reaction of HOBr with taurine. The reaction was monitored by UV absorption spectra. <br> METHODS: Bactericidal activity of TauBr, TauCl and HOCl was tested by incubation of E. coli with the compounds and determined by the pour-plate method. To test the anti-inflammatory activity the compounds were incubated with LPS and IFN-gamma stimulated murine peritoneal macrophages. The production of following mediators was measured: nitrites by Griess reaction; TNF-alpha, IL-6, IL-10, IL-12p40 using capture ELISA. In some experiments the compounds were incubated with either nitrites or H(2)O(2). <br> RESULTS: In our experimental set-up TauBr and HOCl exerted strong bactericidal effects on E. coli (MBC = 110 microM and 8 microM, respectively), while TauCl (< 1000 microM) did not kill test bacteria. However, both, TauBr and TauCl, at noncytotoxic concentrations (< 300 microM) inhibited the cytokine and nitric oxide production by macrophages. H(2)O(2) completely abolished the biological activities of TauBr but not those of TauCl. Nitrites did not affect any activity of TauBr or TauCl while they diminished the HOCl(-) mediated bacterial killing. <br> CONCLUSION: TauBr, despite very low concentration of Br(-) in body fluids, may support TauCl and HOCl in the regulation of inflammatory response and in killing of bacteria by neutrophils. However, TauBr activity in vivo will depend on the presence of H(2)O(2) and possible other mediators of inflammation which can compete with target molecules for TauBr.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723204     DOI: 10.1007/s00011-004-1322-9

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  12 in total

1.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

Review 2.  Taurine and inflammatory diseases.

Authors:  Janusz Marcinkiewicz; Ewa Kontny
Journal:  Amino Acids       Date:  2012-07-19       Impact factor: 3.520

Review 3.  Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Int J Oncol       Date:  2020-07-14       Impact factor: 5.650

4.  Taurine supplementation regulates Iκ-Bα protein expression in adipose tissue and serum IL-4 and TNF-α concentrations in MSG obesity.

Authors:  Luiz Carlos Caetano; Maria Lúcia Bonfleur; Rosane Aparecida Ribeiro; Tarlliza Romanna Nardelli; Camila Lubaczeuski; Juliana do Nascimento da Silva; Everardo Magalhães Carneiro; Sandra Lucinei Balbo
Journal:  Eur J Nutr       Date:  2015-11-30       Impact factor: 5.614

Review 5.  Current Opinion on the Therapeutic Capacity of Taurine-Containing Halogen Derivatives in Infectious and Inflammatory Diseases.

Authors:  Janusz Marcinkiewicz; Markus Nagl; Anthony Kyriakopoulos; Maria Walczewska; Magdalena Skóra; Paulina Skalska
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

6.  Loss of ability to self-heal malaria upon taurine transporter deletion.

Authors:  Denis Delic; Ulrich Warskulat; Elena Borsch; Saad Al-Qahtani; Saleh Al-Quraishi; Dieter Häussinger; Frank Wunderlich
Journal:  Infect Immun       Date:  2010-01-25       Impact factor: 3.441

7.  A systematic review of preclinical studies on the efficacy of taurine for the treatment of rheumatoid arthritis.

Authors:  Aida Malek Mahdavi; Zeinab Javadivala
Journal:  Amino Acids       Date:  2021-04-30       Impact factor: 3.520

Review 8.  Taurine bromamine (TauBr)--its role in immunity and new perspectives for clinical use.

Authors:  Janusz Marcinkiewicz
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

9.  Bromamine T, a stable active bromine compound, prevents the LPS‑induced inflammatory response.

Authors:  Stella Baliou; Michael Sofopoulos; Maria Goulielmaki; Demetrios A Spandidos; Petros Ioannou; Anthony M Kyriakopoulos; Vassilios Zoumpourlis
Journal:  Int J Mol Med       Date:  2021-02-04       Impact factor: 4.101

Review 10.  The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease.

Authors:  Tawar Qaradakhi; Laura Kate Gadanec; Kristen Renee McSweeney; Jemma Rose Abraham; Vasso Apostolopoulos; Anthony Zulli
Journal:  Nutrients       Date:  2020-09-17       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.